These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 1373739)

  • 1. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
    Jaffa AA; Vio CP; Silva RH; Vavrek RJ; Stewart JM; Rust PF; Mayfield RK
    J Clin Invest; 1992 May; 89(5):1460-8. PubMed ID: 1373739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal hyperfiltration states: relationship to kallikrein and kinins.
    Mayfield RK; Jaffa AA; Edmundson AW; Harvey JN
    Agents Actions Suppl; 1992; 38 ( Pt 3)():142-8. PubMed ID: 1281377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
    Jaffa AA; Rust PF; Mayfield RK
    Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental nephron function in rats treated with aprotinin, an inhibitor of kallikrein.
    Kauker ML; Nasjletti A
    J Pharmacol Exp Ther; 1986 Jul; 238(1):155-8. PubMed ID: 3636397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism.
    Jaffa AA; LeRoith D; Roberts CT; Rust PF; Mayfield RK
    Am J Physiol; 1994 Jan; 266(1 Pt 2):F102-7. PubMed ID: 8304475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
    Uehara Y; Hirawa N; Numabe A; Kawabata Y; Ikeda T; Gomi T; Gotoh A; Omata M
    Am J Hypertens; 1997 May; 10(5 Pt 2):83S-88S. PubMed ID: 9160787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.
    Vemulapalli S; Chiu PJ
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system.
    Nasjletti A; Colina-Chourio J
    Fed Proc; 1976 Feb; 35(2):189-93. PubMed ID: 765163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of atrial natriuretic peptide and amiloride on renal haemodynamics and the renal kallikrein-kinin system.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    J Hypertens; 1988 Apr; 6(4):321-7. PubMed ID: 2967862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium lithospermate B improves renal function via the kallikrein-prostaglandin system in rats with renal failure.
    Yokozawa T; Chung HY; Lee TW; Oura H; Nonaka G; Nishioka I
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):893-8. PubMed ID: 1701199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of glucagon-induced renal vasodilation: role of prostaglandins and endothelium-derived relaxing factor.
    Tolins JP
    J Lab Clin Med; 1992 Dec; 120(6):941-8. PubMed ID: 1453114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.